MedPath

Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)

Not Applicable
Completed
Conditions
Infant,Premature
Interventions
Procedure: Pulmonary Function Testing
Procedure: Electrocardiogram
Procedure: Positron Emission Tomography
Procedure: Magnetic Resonance Imaging
Registration Number
NCT03245723
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this research is to determine the effect of premature birth on later heart function and metabolism.

Detailed Description

The purpose of this study is to determine the effects of premature birth on cardiac function, cardiac metabolism, and oxidative stress in a cohort of young adults born prematurely using cardiac positron emission tomography/magnetic resonance imaging and mitochondrial respiration studies.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
52
Inclusion Criteria
  • National Lung Project Cohort only- birth weight <1500g and a gestational age <36 weeks
  • Adults born preterm (Non-National Lung Project) only- gestational age ≤32 weeks OR birth weight ≤ 3lbs 5oz
  • Healthy Controls only- No personal history of known cardiovascular or pulmonary disease
Exclusion Criteria
  • Metabolic Disorders that would affect Fludeoxyglucose uptake
  • Contraindications to positron emission tomography and/or magnetic resonance imaging
  • Pregnancy, if a female of child-bearing potential
  • A personal history of Type I or Type II diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PretermPositron Emission TomographyParticipants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
PretermPulmonary Function TestingParticipants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
PretermMagnetic Resonance ImagingParticipants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
Term - Healthy ControlsPulmonary Function TestingHealthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
PretermElectrocardiogramParticipants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
Term - Healthy ControlsMagnetic Resonance ImagingHealthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
Term - Healthy ControlsElectrocardiogramHealthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
Term - Healthy ControlsPositron Emission TomographyHealthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
Primary Outcome Measures
NameTimeMethod
Cardiac Glucose Uptake During Normoxic Rest (µg/Min)Visit 1 (1 day)

Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

Change in Glucose Uptake From Normoxia to Hypoxia (µg/Min)Visit 1 (1 day)

Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UW Madison

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath